MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
AXSM Axsome Therapeutics
- 90.730
- +0.990+1.10%
Close Dec 20 16:00 ET
- 91.000
- +0.270+0.30%
Post 20:01 ET
4.40BMarket Cap-13.79P/E (TTM)
93.120High87.690Low956.38KVolume88.820Open89.740Pre Close86.61MTurnover2.64%Turnover RatioLossP/E (Static)48.46MShares105.00052wk High47.33P/B3.29BFloat Cap64.11052wk Low--Dividend TTM36.24MShs Float109.940Historical High--Div YieldTTM6.05%Amplitude1.940Historical Low90.561Avg Price1Lot Size
Axsome Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 81.27%104.76M | 86.65%87.17M | -20.70%75M | 440.80%270.6M | 193.50%71.53M | 243.07%57.79M | 429.48%46.7M | 94.58M | 50.04M | 24.37M |
| Operating revenue | 81.27%104.76M | 86.65%87.17M | -20.70%75M | 440.80%270.6M | 193.50%71.53M | 243.07%57.79M | 429.48%46.7M | --94.58M | --50.04M | --24.37M |
| Cost of revenue | 29.16%8.44M | 75.15%8.06M | -16.66%6.3M | 401.44%26.07M | 222.04%7.38M | 239.50%6.53M | 367.85%4.6M | 7.56M | 5.2M | 2.29M |
| Gross profit | 87.91%96.33M | 87.91%79.11M | -21.05%68.7M | 445.36%244.54M | 190.54%64.15M | 243.53%51.26M | 437.21%42.1M | 87.02M | 44.84M | 22.08M |
| Operating expense | 25.53%142.56M | 53.30%155M | 46.85%137.39M | 93.12%427.44M | 53.24%119.22M | 97.93%113.56M | 111.17%101.11M | 144.34%93.56M | 77.49%221.34M | 138.58%77.8M |
| Selling and administrative expenses | 14.88%95.56M | 31.19%103.55M | 33.40%98.97M | 102.90%323.12M | 41.16%86.81M | 103.43%83.19M | 153.32%78.94M | 188.64%74.19M | 138.96%159.25M | 226.66%61.5M |
| Research and development costs | 57.78%45.39M | 142.23%49.85M | 106.99%36.83M | 69.02%97.94M | 109.64%30.8M | 93.37%28.77M | 30.33%20.58M | 41.38%17.79M | -0.20%57.95M | 6.61%14.69M |
| Depreciation amortization depletion | -0.06%1.61M | 0.06%1.59M | 1.08%1.59M | 54.02%6.38M | 0.00%1.61M | 0.00%1.61M | 71.60%1.59M | --1.57M | --4.14M | --1.61M |
| -Depreciation and amortization | -0.06%1.61M | 0.06%1.59M | 1.08%1.59M | 54.02%6.38M | 0.00%1.61M | 0.00%1.61M | 71.60%1.59M | --1.57M | --4.14M | --1.61M |
| Operating profit | 25.79%-46.23M | -28.61%-75.89M | -950.90%-68.69M | -3.63%-182.91M | 1.17%-55.07M | -46.75%-62.3M | -47.36%-59M | 82.93%-6.54M | -41.53%-176.5M | -70.87%-55.72M |
| Net non-operating interest income expense | -161.29%-1.98M | 52.42%-1.3M | 52.21%-1.08M | 12.02%-6.45M | 46.94%-702K | 68.60%-757K | -20.96%-2.73M | -68.58%-2.26M | -28.77%-7.34M | 3.29%-1.32M |
| Non-operating interest expense | 161.29%1.98M | -52.42%1.3M | -52.21%1.08M | -12.02%6.45M | -46.94%702K | -68.60%757K | 20.96%2.73M | 68.58%2.26M | 28.77%7.34M | -3.29%1.32M |
| Other net income (expense) | -9,206.11%-16.39M | 64.32%-2.16M | 771.60%1.41M | -1,383.26%-48.92M | -928.74%-43.21M | 328.57%180K | -803.84%-6.05M | 162K | -3.3M | -4.2M |
| Special income (charges) | -9,206.11%-16.39M | 64.32%-2.16M | 771.60%1.41M | -1,383.26%-48.92M | -928.74%-43.21M | 328.57%180K | -803.84%-6.05M | --162K | ---3.3M | ---4.2M |
| -Less：Restructuring and merger&acquisition | 9,206.11%16.39M | -64.32%2.16M | -771.60%-1.41M | 1,383.26%48.92M | 928.74%43.21M | -328.57%-180K | 803.84%6.05M | ---162K | --3.3M | --4.2M |
| Income before tax | -2.74%-64.6M | -17.05%-79.35M | -691.35%-68.36M | -27.33%-238.28M | -61.62%-98.98M | -40.28%-62.88M | -63.59%-67.79M | 78.20%-8.64M | -43.50%-187.13M | -80.25%-61.24M |
| Income tax | 0 | 0 | 0 | 960K | -325K | -678K | -617K | 2.58M | 0 | 0 |
| Net income | -3.86%-64.6M | -18.13%-79.35M | -509.35%-68.36M | -27.84%-239.24M | -61.09%-98.65M | -38.77%-62.2M | -62.10%-67.17M | 71.69%-11.22M | -43.50%-187.13M | -80.25%-61.24M |
| Net income continuous Operations | -3.86%-64.6M | -18.13%-79.35M | -509.35%-68.36M | -27.84%-239.24M | -61.09%-98.65M | -38.77%-62.2M | -62.10%-67.17M | 71.69%-11.22M | -43.50%-187.13M | -80.25%-61.24M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -3.86%-64.6M | -18.13%-79.35M | -509.35%-68.36M | -27.84%-239.24M | -61.09%-98.65M | -38.77%-62.2M | -62.10%-67.17M | 71.69%-11.22M | -43.50%-187.13M | -80.25%-61.24M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -3.86%-64.6M | -18.13%-79.35M | -509.35%-68.36M | -27.84%-239.24M | -61.09%-98.65M | -38.77%-62.2M | -62.10%-67.17M | 71.69%-11.22M | -43.50%-187.13M | -80.25%-61.24M |
| Basic earnings per share | -1.52%-1.34 | -8.44%-1.67 | -453.85%-1.44 | -14.57%-5.27 | -47.52%-2.08 | -23.36%-1.32 | -45.28%-1.54 | 74.76%-0.26 | -32.56%-4.6 | -56.67%-1.41 |
| Diluted earnings per share | -1.52%-1.34 | -8.44%-1.67 | -453.85%-1.44 | -14.57%-5.27 | -47.52%-2.08 | -23.36%-1.32 | -45.28%-1.54 | 74.76%-0.26 | -32.56%-4.6 | -56.67%-1.41 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.